Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies

AIMS: Clinical trials have shown that anticoagulation with vitamin K antagonists (VKAs), e.g. warfarin, decreases the risk of stroke in patients with atrial fibrillation (AF); however, increased bleeding risk is one of the safety concerns. The primary objective was to conduct a systematic review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roskell, Neil S., Samuel, Miny, Noack, Herbert, Monz, Brigitta U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663334/
https://www.ncbi.nlm.nih.gov/pubmed/23407628
http://dx.doi.org/10.1093/europace/eut001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663334/
https://www.ncbi.nlm.nih.gov/pubmed/23407628
http://dx.doi.org/10.1093/europace/eut001

Ejemplares similares